Bruker Statistics
Total Valuation
Bruker has a market cap or net worth of $5.13 billion. The enterprise value is $6.88 billion.
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | Mar 23, 2026 |
Share Statistics
Bruker has 152.22 million shares outstanding. The number of shares has increased by 1.54% in one year.
| Current Share Class | 152.22M |
| Shares Outstanding | 152.22M |
| Shares Change (YoY) | +1.54% |
| Shares Change (QoQ) | +0.46% |
| Owned by Insiders (%) | 31.88% |
| Owned by Institutions (%) | 91.79% |
| Float | 103.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 15.94 |
| PS Ratio | 1.49 |
| Forward PS | 1.41 |
| PB Ratio | 2.09 |
| P/TBV Ratio | 557.92 |
| P/FCF Ratio | 118.54 |
| P/OCF Ratio | 38.28 |
| PEG Ratio | 2.11 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 13.76, with an EV/FCF ratio of 158.82.
| EV / Earnings | n/a |
| EV / Sales | 2.00 |
| EV / EBITDA | 13.76 |
| EV / EBIT | 24.60 |
| EV / FCF | 158.82 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.81.
| Current Ratio | 1.73 |
| Quick Ratio | 0.81 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 3.67 |
| Debt / FCF | 47.18 |
| Interest Coverage | 4.64 |
Financial Efficiency
Return on equity (ROE) is -0.38% and return on invested capital (ROIC) is -2.60%.
| Return on Equity (ROE) | -0.38% |
| Return on Assets (ROA) | 2.90% |
| Return on Invested Capital (ROIC) | -2.60% |
| Return on Capital Employed (ROCE) | 5.63% |
| Weighted Average Cost of Capital (WACC) | 7.38% |
| Revenue Per Employee | $310,014 |
| Profits Per Employee | -$2,030 |
| Employee Count | 11,085 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.65 |
Taxes
In the past 12 months, Bruker has paid $29.30 million in taxes.
| Income Tax | 29.30M |
| Effective Tax Rate | 139.52% |
Stock Price Statistics
The stock price has decreased by -22.50% in the last 52 weeks. The beta is 1.19, so Bruker's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -22.50% |
| 50-Day Moving Average | 40.32 |
| 200-Day Moving Average | 39.91 |
| Relative Strength Index (RSI) | 36.21 |
| Average Volume (20 Days) | 2,147,004 |
Short Selling Information
The latest short interest is 10.66 million, so 7.00% of the outstanding shares have been sold short.
| Short Interest | 10.66M |
| Short Previous Month | 10.39M |
| Short % of Shares Out | 7.00% |
| Short % of Float | 10.29% |
| Short Ratio (days to cover) | 5.01 |
Income Statement
In the last 12 months, Bruker had revenue of $3.44 billion and -$22.50 million in losses. Loss per share was -$0.15.
| Revenue | 3.44B |
| Gross Profit | 1.65B |
| Operating Income | 279.60M |
| Pretax Income | 21.00M |
| Net Income | -22.50M |
| EBITDA | 499.90M |
| EBIT | 279.60M |
| Loss Per Share | -$0.15 |
Full Income StatementBalance Sheet
The company has $298.80 million in cash and $2.04 billion in debt, with a net cash position of -$1.74 billion or -$11.46 per share.
| Cash & Cash Equivalents | 298.80M |
| Total Debt | 2.04B |
| Net Cash | -1.74B |
| Net Cash Per Share | -$11.46 |
| Equity (Book Value) | 2.51B |
| Book Value Per Share | 16.15 |
| Working Capital | 933.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $134.10 million and capital expenditures -$90.80 million, giving a free cash flow of $43.30 million.
| Operating Cash Flow | 134.10M |
| Capital Expenditures | -90.80M |
| Depreciation & Amortization | 220.30M |
| Net Borrowing | -491.30M |
| Free Cash Flow | 43.30M |
| FCF Per Share | $0.28 |
Full Cash Flow StatementMargins
Gross margin is 47.95%, with operating and profit margins of 8.14% and -0.25%.
| Gross Margin | 47.95% |
| Operating Margin | 8.14% |
| Pretax Margin | 0.61% |
| Profit Margin | -0.25% |
| EBITDA Margin | 14.55% |
| EBIT Margin | 8.14% |
| FCF Margin | 1.26% |
Dividends & Yields
This stock pays an annual dividend of $0.20, which amounts to a dividend yield of 0.59%.
| Dividend Per Share | $0.20 |
| Dividend Yield | 0.59% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.54% |
| Shareholder Yield | -0.94% |
| Earnings Yield | -0.44% |
| FCF Yield | 0.84% |
Dividend DetailsAnalyst Forecast
The average price target for Bruker is $49.54, which is 46.92% higher than the current price. The consensus rating is "Buy".
| Price Target | $49.54 |
| Price Target Difference | 46.92% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 4.68% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bruker has an Altman Z-Score of 2.43 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.43 |
| Piotroski F-Score | 5 |
